Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000036442
JPRN-UMIN000036442
Recruiting
未知

Examination of bone mineral density, serum sclerostin values, and bone metabolism after bone mineral density up gymnastics in osteoporosis patients - Examination of bone-related factors after exercise in osteoporosis patients

Shinshu University School of Medicine0 sites100 target enrollmentApril 9, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Shinshu University School of Medicine
Enrollment
100
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2019
End Date
April 3, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\. Patients who have severe renal failure 2\. Patients who have had fractures within a year 3\. Patients whom we have evaluated as inapropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Opportunistically determined bone mineral density:Comparison of QCT-based bone mineral density with opportunistically determined bone mineral density in the spineM81.9Osteoporosis, unspecified
DRKS00031221Institut für Neuroradiologie500
Recruiting
Not Applicable
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritis
DRKS00021182Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin60
Completed
Not Applicable
Evaluation of bone mineral density and bone metabolism during treatment with januskinaseinhibitors baricitinib or tofacintib in patients with rheumatoid arthritisM05.80M06.00
DRKS00020780Campus Kerckhoff der Justus Liebig Universität Giessen, Abteiliung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin89
Active, not recruiting
Phase 1
study to assess the changes in bone health after changing from a TDF based regimen to Bicetegravir-Tenofovir Alafenamide-Emtricitavine based treatment
EUCTR2018-004499-36-ESConsorci Mar Parc de Salut de Barcelona60
Not yet recruiting
Not Applicable
Determining Bone strength measurement standards- comparing with existing standards to look for bone lossHealth Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
CTRI/2018/10/016060KASTURBA MEDICAL COLLEGE